Literature DB >> 20199013

Enhanced visual acuity and image perception following correction of highly aberrated eyes using an adaptive optics visual simulator.

Karolinne Maia Rocha1, Laurent Vabre, Nicolas Chateau, Ronald R Krueger.   

Abstract

PURPOSE: To evaluate the changes in visual acuity and visual perception generated by correcting higher order aberrations in highly aberrated eyes using a large-stroke adaptive optics visual simulator.
METHODS: A crx1 Adaptive Optics Visual Simulator (Imagine Eyes) was used to correct and modify the wavefront aberrations in 12 keratoconic eyes and 8 symptomatic postoperative refractive surgery (LASIK) eyes. After measuring ocular aberrations, the device was programmed to compensate for the eye's wavefront error from the second order to the fifth order (6-mm pupil). Visual acuity was assessed through the adaptive optics system using computer-generated ETDRS opto-types and the Freiburg Visual Acuity and Contrast Test.
RESULTS: Mean higher order aberration root-mean-square (RMS) errors in the keratoconus and symptomatic LASIK eyes were 1.88+/-0.99 microm and 1.62+/-0.79 microm (6-mm pupil), respectively. The visual simulator correction of the higher order aberrations present in the keratoconus eyes improved their visual acuity by a mean of 2 lines when compared to their best spherocylinder correction (mean decimal visual acuity with spherocylindrical correction was 0.31+/-0.18 and improved to 0.44+/-0.23 with higher order aberration correction). In the symptomatic LASIK eyes, the mean decimal visual acuity with spherocylindrical correction improved from 0.54+/-0.16 to 0.71+/-0.13 with higher order aberration correction. The visual perception of ETDRS letters was improved when correcting higher order aberrations.
CONCLUSIONS: The adaptive optics visual simulator can effectively measure and compensate for higher order aberrations (second to fifth order), which are associated with diminished visual acuity and perception in highly aberrated eyes. The adaptive optics technology may be of clinical benefit when counseling patients with highly aberrated eyes regarding their maximum subjective potential for vision correction. Copyright 2010, SLACK Incorporated.

Entities:  

Mesh:

Year:  2010        PMID: 20199013     DOI: 10.3928/1081597X-20101215-08

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  7 in total

1.  Optimizing wavefront-guided corrections for highly aberrated eyes in the presence of registration uncertainty.

Authors:  Yue Shi; Hope M Queener; Jason D Marsack; Ayeswarya Ravikumar; Harold E Bedell; Raymond A Applegate
Journal:  J Vis       Date:  2013-06-11       Impact factor: 2.240

2.  Optics and neural adaptation jointly limit human stereovision.

Authors:  Cherlyn J Ng; Randolph Blake; Martin S Banks; Duje Tadin; Geunyoung Yoon
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

Review 3.  Adaptive optics for studying visual function: a comprehensive review.

Authors:  Austin Roorda
Journal:  J Vis       Date:  2011-06-16       Impact factor: 2.240

Review 4.  Imaging single cells in the living retina.

Authors:  David R Williams
Journal:  Vision Res       Date:  2011-05-10       Impact factor: 1.886

5.  Relation of Corneal Astigmatism with Various Corneal Image Quality Parameters in a Large Cohort of Naïve Corneas.

Authors:  Mohamed Omar Yousif; Rania Serag Elkitkat; Noha Abdelsadek Alaarag; Abdelrhman Shams; Hesham Mohamed Gharieb
Journal:  Clin Ophthalmol       Date:  2020-08-04

6.  Design of an integrated hardware interface for AOSLO image capture and cone-targeted stimulus delivery.

Authors:  Qiang Yang; David W Arathorn; Pavan Tiruveedhula; Curtis R Vogel; Austin Roorda
Journal:  Opt Express       Date:  2010-08-16       Impact factor: 3.894

7.  Habitual higher order aberrations affect Landolt but not Vernier acuity.

Authors:  Jenny L Reiniger; Anne C Lobecke; Ramkumar Sabesan; Michael Bach; Frenne Verbakel; John de Brabander; Frank G Holz; Tos T J M Berendschot; Wolf M Harmening
Journal:  J Vis       Date:  2019-05-01       Impact factor: 2.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.